Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:6.2.1.1 (ACS)
 78,556 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Thrombosis superimposed on arteriosclerosis is the principal cause of mortality and morbidity in patients with arteriosclerosis. The use of antiplatelet agents and anticoagulants in the treatment of arteriosclerosis is well established, based on many large randomized trials. Aspirin is indicated for primary prevention in patients at increased risk of developing symptomatic atherosclerotic vascular disease. For patients with known vascular disease, antiplatelet therapy with aspirin is a well-established treatment. For high-risk patients such as those with acute coronary syndromes (ACS; unstable angina, myocardial infarction), dual antiplatelet therapy with aspirin and clopidogrel is indicated, based on results of the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) trial. Platelet glycoprotein IIb/IIIa agents are powerful inhibitors of platelet function and are also effective in ACS, but the benefit is confined to high-risk patients. Anticoagulation with heparin or low-molecular-weight heparin (eg, enoxaparin) is also effective, with an approximately 50% reduction in cardiovascular events. These agents are also indicated for patients undergoing percutaneous coronary intervention. Prolonged dual antiplatelet therapy (at least 6 months) is recommended for patients receiving drug-eluting stents. The efficacy of antiplatelet therapy is thus well established in treating atherothrombosis, but aggressive therapy is associated with an increased bleeding risk. Newer agents may provide improved efficacy with a lower risk of bleeding.
 ...
PMID:Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices. 1771 74

The fingertip-pulse waveform carries abundant information regarding human physiological condition that is fundamental for directly extracting physiological parameters. Making the surfaces of ordinary objects that are often in contact with fingertips, such as tables and computers, capable of perceiving dynamic epidermal pulse signals has great significance for accurately assessing health conditions without restrictions on time and place. Here, we demonstrate the materials and design of a nanohemispherical pressure sensor that can be attached to ubiquitous objects' surfaces to monitor fingertip pulse. The portable sensor achieved an ultrasensitivity of 49.8 mV/Pa, a prominent response time of less than 6 ms, and long-term durability of more than 4 months. As demonstrated, the sensor is utilized to measure subtle fingertip-pulse waves and extract characteristic points of the waveform on the surface of keyboards, mobile phones, and human skin. Given the superior performance of the sensor, a real-time, wireless arteriosclerosis monitoring system is developed. By analyzing the characteristic parameters of the pulse waveforms measured from 54 volunteer participants, the antidiastole of arteriosclerosis could be instructively diagnosed. The sensor proposed in this work is expected to be a competitive alternative to current complicated medical equipment and to be extensively applied in wireless cardiovascular monitoring systems.
ACS Appl Mater Interfaces 2019 Dec 18
PMID:Ultrasensitive Fingertip-Contacted Pressure Sensors To Enable Continuous Measurement of Epidermal Pulse Waves on Ubiquitous Object Surfaces. 3181 2